Business
Chlormet Receives Economic Analysis of Medical Marijuana
Chlormet Receives Economic Analysis of Medical Marijuana Vancouver, British Columbia CANADA...
About this update from Cullinan Metals Corp
[{"type":"text","content":"Chlormet Receives Economic Analysis of Medical MarijuanaChlormet Receives Economic Analysis of Medical Marijuana \n\nVancouver, British Columbia CANADA, April 02, 2014 /FSC/ - Chlormet Technologies Inc (CMT - TSX Venture), (\"Chlormet\" or the \"Company\") is pleased to announce that it has received a final copy of its independent economic analysis on the Company's entry into Canada's emerging medical marijuana industry.  \n\nThe report provides the Company with an in depth look into the Canadian medical marijuana sector and an assessment of the market opportunity for the recently announced exclusive option to acquire 100% of AAA Heidelberg, a private Ontario company, previously referred to as PrivCo (see news release dated March 27, 2014). \nAbout AAA Heidelberg:\n\nAAA Heidelberg currently owns a secure 8,800 square foot commercial building and land located in London, Ontario.  Since December 2013 AAA Heidelberg has had an application pending with Health Canada for a new MMPR (Marihuana for Medical Purposes Regulations) license for the production of up to 1,320 pounds of marijuana in the first year.  \n\nAs a result of the early application, the licensing process is well under way. Upon completion of the interior of the building to the strict guidelines of Heath Canada, which will include four grow rooms, labs, offices and secure storage for the product, Health Canada will be asked to perform a final inspection to complete the licensing process.\n\nAAA Heidelberg's personnel includes an experienced grow-master who is currently a 'designated grower' under current MMAR licensing.  The current crops, that are being grown under the continuing MMAR licensing and are currently thriving due to the injunction against the Health Canada, include ten different strains of marijuana that range from high CBD content to high THC content and are anticipated to be sold for between $5 to $15 per gram depending on the strain.\n\nBackground:\n\nAs of April 1, 2014, new producers will be required to be licensed by Health Canada and to conform to strict new regulations.  As per Chlormet's recently received economic analysis, \"The new regulations suggest that the medical marijuana industry will be put on the same footing as the pharmaceutical manufacturing sector. The regulations are quite onerous i...